Ginkgo Bioworks (DNA) Reports In-Line Q2 EPS; Offers FY23 Revenue Guidance

Go back to Ginkgo Bioworks (DNA) Reports In-Line Q2 EPS; Offers FY23 Revenue Guidance
Genentech, Inc. (NYSE: DNA) Delayed: 8.86 -0.18 (1.99%)
Previous Close $9.04    52 Week High $99.14 
Open $8.75    52 Week Low $69.17 
Day High $9.55    P/E 2.76 
Day Low $8.75    EPS $3.21 
Volume 969,505